CMS Drug Pricing Guidance Proposed In Medicaid Commission Report
Executive Summary
The Centers for Medicare & Medicaid Services should issue guidance on how drug manufacturers determine pricing, the Medicaid Commission's reform proposal recommends
You may also be interested in...
Medicaid Reform Bill Is A Draw For Pharma; Pharmacy Continues Its Fight
The conference report on budget reconciliation creates a new definition of the Medicaid federal upper limit for pharmacy reimbursement for multiple source drugs
Medicaid Reform Bill Is A Draw For Pharma; Pharmacy Continues Its Fight
The conference report on budget reconciliation creates a new definition of the Medicaid federal upper limit for pharmacy reimbursement for multiple source drugs
House Medicaid Reform Could “Refine” Average Manufacturer Price
A House Energy & Commerce Committee draft document on Medicaid reform recommends revising the definition of average manufacturer price to better suit pharmacy reimbursement